4
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2483 | Dacomitinib | PF-299804,PF-00299804,PF299 | Apoptosis , EGFR |
Dacomitinib (PF299)(PF299804; PF-00299804) is a highly selective, orally bioavailable small-molecule inhibitor of the HER family of tyrosine kinases with IC50 of 6, 45.7 and 73.7 nM for EGFR, ERBB2, and ERBB4, respective... | |||
T19965 | Dacomitinib hydrate | PF 299804,PF00299804,PF 00299804,PF-00299804,PF299804,PF-299804 | EGFR |
Dacomitinib hydrate (PF 299804) is a highly selective and second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor family of tyrosine kinases. Dacomitinib specifically and irreversibly binds... | |||
T67152 | Dacomitinib Intermediate 2 | N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine | Others |
Dacomitinib Intermediate 2 (N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine) has anticancer activity and can be used to study lung cancer. | |||
T23950 | Dacomitinib metabolite M2 | Dacomitinib cysteine conjugate,UNII-SOA52D3NLL | |
Dacomitinib metabolite M2 is also known as Dacomitinib cysteine conjugate. Dacomitinib inhibits both the wild-type (WT) EGFR and EGFR T790M. |